Astrana Health, Inc.
ASTH
$29.93
-$0.75-2.45%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 2.58M | 2.31M | 5.55M | 2.75M | 1.60M |
| Total Other Revenue | 652.23M | 618.08M | 659.66M | 475.96M | 484.66M |
| Total Revenue | 654.81M | 620.39M | 665.21M | 478.71M | 486.27M |
| Cost of Revenue | 576.84M | 549.06M | 614.73M | 405.22M | 412.81M |
| Gross Profit | 77.97M | 71.33M | 50.48M | 73.49M | 73.46M |
| SG&A Expenses | 50.73M | 42.49M | 41.63M | 37.80M | 35.95M |
| Depreciation & Amortization | 6.90M | 6.85M | 8.13M | 7.26M | 7.44M |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 634.47M | 598.40M | 664.49M | 450.29M | 456.20M |
| Operating Income | 20.34M | 21.99M | 720.00K | 28.43M | 30.07M |
| Income Before Tax | 16.83M | 9.60M | -1.90M | 26.81M | 31.90M |
| Income Tax Expenses | 6.61M | 3.38M | 5.88M | 7.83M | 10.03M |
| Earnings from Continuing Operations | 10.22M | 6.22M | -7.78M | 18.98M | 21.87M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -793.00K | 471.00K | 826.00K | -2.89M | -2.70M |
| Net Income | 9.42M | 6.69M | -6.95M | 16.09M | 19.17M |
| EBIT | 20.34M | 21.99M | 720.00K | 28.43M | 30.07M |
| EBITDA | 27.24M | 28.84M | 8.85M | 35.69M | 37.51M |
| EPS Basic | 0.19 | 0.14 | -0.15 | 0.34 | 0.40 |
| Normalized Basic EPS | 0.20 | 0.15 | 0.01 | 0.27 | 0.36 |
| EPS Diluted | 0.19 | 0.14 | -0.15 | 0.33 | 0.40 |
| Normalized Diluted EPS | 0.20 | 0.15 | 0.01 | 0.27 | 0.36 |
| Average Basic Shares Outstanding | 49.19M | 48.47M | 46.34M | 47.69M | 47.62M |
| Average Diluted Shares Outstanding | 49.47M | 48.85M | 46.34M | 48.22M | 47.98M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | 8.26% | 81.52% | -- | -- | -- |